Mia's Feed
Medical News & Research

Long-Term Fatigue Can Persist for Up to a Year After a Mini-Stroke

Long-Term Fatigue Can Persist for Up to a Year After a Mini-Stroke

Share this article

New research reveals that fatigue can last up to a year after a transient ischemic attack, highlighting the importance of follow-up care for TIA patients.

2 min read

Transient ischemic attacks (TIAs), commonly known as 'ministrokes,' can have lasting effects beyond the immediate neurological symptoms. Recent research indicates that more than half of individuals who experience a TIA may suffer from fatigue that persists for up to a year after the event. The study highlights the importance for healthcare providers to monitor and address fatigue in TIA patients, as it can significantly impact recovery and quality of life.

The research, published in Neurology and conducted by Danish researchers, involved tracking fatigue levels in patients shortly after their TIA and during follow-up visits at 3, 6, and 12 months. Results showed that over 60% of patients experienced pathological fatigue at the start of the study, with more than half continuing to report fatigue after a year. Interestingly, factors such as the presence of acute infarction or a history of anxiety or depression played a role in fatigue outcomes.

This study underscores the need to reconsider post-TIA care, emphasizing ongoing fatigue assessment and management. Healthcare professionals are encouraged to incorporate fatigue evaluations into follow-up protocols, as early identification and intervention could improve long-term outcomes. Experts suggest that rehabilitation and support should be extended to TIA patients similarly to stroke patients, given the comparable fatigue levels observed.

Continued research is necessary to understand why some individuals develop prolonged fatigue after a TIA, and how best to support recovery in these cases.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Inhaler Technology Offers New Hope for Premature Infants with Respiratory Distress

A new handheld dry powder inhaler developed by Virginia Commonwealth University offers a noninvasive, efficient treatment for premature infants suffering from respiratory distress, promising faster, targeted therapy to save lives.

WHO Confirms No Evidence of Harm from Vaccine Ingredient Opposed by US Panel

The World Health Organization affirms the safety of thimerosal, a vaccine preservative, amid recent US panel opposition. Extensive research shows no harm, reaffirming its vital role in global immunization efforts.

New Study Investigates the Genetic Connection Between Cannabis Use and Psychiatric Disorders

A recent study uncovers the genetic relationship between cannabis use disorder and various psychiatric conditions, revealing potential pathways for early intervention and treatment strategies.